Clinicopathological and biological significance of CDC28 protein kinase regulatory subunit 2 overexpression in human gastric cancer

  • Authors:
    • Fumiaki Tanaka
    • Shinji Matsuzaki
    • Koshi Mimori
    • Yoshiaki Kita
    • Hiroshi Inoue
    • Masaki Mori
  • View Affiliations

  • Published online on: May 25, 2011     https://doi.org/10.3892/ijo.2011.1056
  • Pages: 361-372
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

CDC28 protein kinase regulatory subunit 2 (CKS2) is a cyclin-dependent kinase subunit (CKS) family member that participates in cell cycle regulation. Few studies have investi­gated its involvement in gastric cancer. In this study, we focused on the clinical and biological significance of CKS2 over­expression in gastric cancer. The expression of CKS2 mRNA was studied by real-time quantitative reverse transcription polymerase chain reaction, and the expression status in each tumor was examined to varify whether any correlation existed with clinical and pathological factors. In addition, an immuno­histochemical study was performed in selected samples. Moreover, we examined the impact of CKS2-siRNA in a gastric cancer cell line. A significantly higher expression of CKS2 mRNA was found in tumor tissues compared to paired normal tissues (p<0.01). Immunohistochemical analyses led to similar results. The overall five-year survival rate was signifi­cantly higher in the low CKS2 expression group (59.9%) than in the high CKS2 expression group (23.9%) (p<0.01). Univariate and multivariate analysis showed that CKS2 expression status was an independent prognostic factor (relative risk, 1.41; 95% confidence interval, 1.01-1.97; p<0.05). Moreover, the inhibition of cellular proliferation by CKS2-siRNA was observed in a gastric cancer cell line. CKS2 is one of the gastric cancer-related genes that correlates with biological aggressiveness and poor prognosis of gastric cancer. Thus, CKS2 is a possible candidate gene for diagnosis, as well as targeted molecular diagnosis and therapy in gastric cancer.

Related Articles

Journal Cover

August 2011
Volume 39 Issue 2

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Tanaka F, Matsuzaki S, Mimori K, Kita Y, Inoue H and Mori M: Clinicopathological and biological significance of CDC28 protein kinase regulatory subunit 2 overexpression in human gastric cancer. Int J Oncol 39: 361-372, 2011
APA
Tanaka, F., Matsuzaki, S., Mimori, K., Kita, Y., Inoue, H., & Mori, M. (2011). Clinicopathological and biological significance of CDC28 protein kinase regulatory subunit 2 overexpression in human gastric cancer. International Journal of Oncology, 39, 361-372. https://doi.org/10.3892/ijo.2011.1056
MLA
Tanaka, F., Matsuzaki, S., Mimori, K., Kita, Y., Inoue, H., Mori, M."Clinicopathological and biological significance of CDC28 protein kinase regulatory subunit 2 overexpression in human gastric cancer". International Journal of Oncology 39.2 (2011): 361-372.
Chicago
Tanaka, F., Matsuzaki, S., Mimori, K., Kita, Y., Inoue, H., Mori, M."Clinicopathological and biological significance of CDC28 protein kinase regulatory subunit 2 overexpression in human gastric cancer". International Journal of Oncology 39, no. 2 (2011): 361-372. https://doi.org/10.3892/ijo.2011.1056